QuellTX
Hayley Thomas is a seasoned professional with extensive experience in risk management and internal auditing. Currently serving in the Global Controls & Compliance role for Tesco since March 2023, Hayley previously held significant positions at Freeline, including Director of Risk & Internal Audit and Financial Controller from January 2019 to December 2022. Prior experience includes a tenure at easyJet as Risk Manager and Senior Internal Financial Controls Specialist from February 2012 to September 2017. Additionally, Hayley spent over seven years at Harrods in various roles within Group Internal Audit, and began a career at Baker Tilly as Audit Senior from 2000 to 2004.
This person is not in any teams
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.